121 related articles for article (PubMed ID: 29199)
1. A comparison of the effects of anti-psychotic drugs on pituitary, striatal and limbic system post-synaptic dopamine receptors.
Meltzer HY; Simonovic M; Fang V; Piyakalamala S; Young M
Life Sci; 1978 Aug; 23(6):605-9. PubMed ID: 29199
[No Abstract] [Full Text] [Related]
2. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
Płaźnik A; Kostowski W
Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
[No Abstract] [Full Text] [Related]
3. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
Bartholini G
Adv Biochem Psychopharmacol; 1977; 16():607-11. PubMed ID: 18902
[No Abstract] [Full Text] [Related]
4. Comparison of the effects of (-)deprenyl, 1-phenyl-2-propyl-aminopentane (MK-306) and amphetamine on the striatal and limbic dopaminergic system.
Timár J; Yasar S; Knoll B; Knoll J
Acta Physiol Hung; 1990; 75 Suppl():279-80. PubMed ID: 2115233
[No Abstract] [Full Text] [Related]
5. Comparison of the effects of substituted benzamides and standard neuroleptics on the binding of 3H-spiroperidol in the rat pituitary and striatum with in vivo effects on rat prolactin secretion.
Meltzer HY; So R; Miller RJ; Fang VS
Life Sci; 1979 Aug; 25(7):573-83. PubMed ID: 41148
[No Abstract] [Full Text] [Related]
6. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
Hertel P
Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of antipsychotic drugs.
Borison RL
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):25-8. PubMed ID: 2858475
[TBL] [Abstract][Full Text] [Related]
8. The dopamine autoreceptor agonist, (+/-)-trans-1,3,4,4a5,10b-hexahydro-4-propyl-2H [1]benzopyrano [3,4-b] pyridin-9-ol hydrochloride (CGS 15855A), modulates striatal dopamine metabolism and prolactin release.
Iyengar S; Hausler A; Kim HS; Marien M; Altar CA; Wood PL
Neuropharmacology; 1989 Jan; 28(1):27-31. PubMed ID: 2522597
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of prolactin on the dopaminergic receptor sensitivity in striatal and limbic areas after experimentally-induced alterations in its peripheral levels.
Cebeira M; Hernandez ML; Rodriguez de Fonseca F; de Miguel R; Fernandez-Ruiz JJ; Ramos JA
Life Sci; 1991; 48(6):531-41. PubMed ID: 1671524
[TBL] [Abstract][Full Text] [Related]
10. Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.
Scatton B; Boireau A; Garret C; Glowinski J; Julou L
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):169-75. PubMed ID: 13318
[No Abstract] [Full Text] [Related]
11. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
[TBL] [Abstract][Full Text] [Related]
12. The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools.
Robinson SE; Berney S; Mishra R; Sulser F
Psychopharmacology (Berl); 1979 Aug; 64(2):141-7. PubMed ID: 40288
[No Abstract] [Full Text] [Related]
13. The effect of chronic neuroleptic administration on cerebral dopamine receptor function.
Rupniak MN; Jenner P; Marsden CD
Life Sci; 1983 May; 32(20):2289-311. PubMed ID: 6133203
[TBL] [Abstract][Full Text] [Related]
14. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
[TBL] [Abstract][Full Text] [Related]
15. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
Prosser ES; Csernansky JG; Hollister LE
Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
[TBL] [Abstract][Full Text] [Related]
16. During one year's neuroleptic treatment in rats striatal dopamine receptor blockade decreases but serum prolactin levels remain elevated.
Dyer RG; Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
Life Sci; 1981 Jan; 28(2):167-74. PubMed ID: 6114373
[No Abstract] [Full Text] [Related]
17. The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro.
Howard JL; Large BT; Wedley S; Pullar IA
Life Sci; 1978 Aug; 23(6):599-603. PubMed ID: 29198
[No Abstract] [Full Text] [Related]
18. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
[TBL] [Abstract][Full Text] [Related]
19. The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations.
Rubin RT; Hays SE
Psychoneuroendocrinology; 1980; 5(2):121-37. PubMed ID: 6104835
[No Abstract] [Full Text] [Related]
20. Mesolimbic system and tardive dyskinesia: new perspectives for therapy.
Cools AR
Mod Probl Pharmacopsychiatry; 1983; 21():111-23. PubMed ID: 6140628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
